Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
08/2001
08/30/2001WO2001062087A2 Fungicidal agents containing pyrrolidones as their active agents and use thereof for treating plants
08/30/2001WO2001014576A3 Process and intermediates for the preparation of isoxazolecaroxamides and analogues
08/30/2001WO2000071510A3 INHIBITORS OF FACTOR Xa
08/30/2001US20010018528 Heating ammonia with methanol in presence of a catalyst; reacting with gamma-butyrolactone
08/30/2001US20010018456 Use of a RAR-gamma-specific agonist ligand for increasing the rate of apoptosis
08/30/2001US20010018450 Amycomycin, a process for its production and its use as a pharmaceutical
08/30/2001US20010018441 Antiinflammatory agent, immunosuppressant, anticancer agents, antiarthritic agents
08/30/2001US20010018423 Anticoagulant agents
08/30/2001CA2400435A1 Novel compounds
08/30/2001CA2400434A1 Novel compounds
08/30/2001CA2400293A1 Novel compounds
08/30/2001CA2400224A1 Fungicidal agents containing pyrrolidones as their active agents and use thereof for treating plants
08/30/2001CA2397234A1 Novel use of phenylheteroalkylamine derivatives
08/29/2001EP1127884A1 Novel malonic acid derivatives, processes for their preparation, their use as inhibitor of factor XA activity and pharmaceutical compositions containing them
08/29/2001EP1127880A2 Phenylacetic acid derivatives substituted by a heterocycle and their use as A-II antagonists and as inhibitors of smooth muscle cell proliferation
08/29/2001EP1127871A1 New esters derived from substituted phenyl-cyclohexyl compounds
08/29/2001EP1127869A1 Novel compounds and medicinal use thereof
08/29/2001EP1127055A2 Stereoselective process for producing cryptophycins
08/29/2001EP1127045A2 Use of triphenylbutene derivatives for the treatment of neurological disorders
08/29/2001EP1126838A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
08/29/2001EP0825983B1 Process for the preparation of 2,2'-bipyrrolyl-pyrromethene (prodigiosins) derivatives
08/29/2001EP0809624B1 Alkylcarboxy amino acids-modulators of the kainate receptor
08/29/2001EP0809622B1 Anti-inflammatory benzoic acid derivatives
08/29/2001CN1310700A Method for producing ortho-alkylated benzoic acid derivatives
08/28/2001US6281391 Reacting hydroxyamide compound with lithiating agent comprising 4-methylthiophenyllithium in non-reacting solvent to form methylthiophenyl-hydroxyketone compound
08/28/2001US6281364 Process for the preparation of 3-amino-2-oxo-pyrrolidines, novel intermediates and their use
08/28/2001US6281314 Containing maleimide compound
08/28/2001US6281243 Derivatives of azetidine and pyrrolidine
08/28/2001US6281226 Pleuromutilin derivatives as antimicrobials
08/28/2001US6280859 Light-emitting material for organo-electroluminescence device and for organic electroluminescence device which the material is applied
08/28/2001CA2017252C Retroviral protease inhibiting compounds
08/28/2001CA2015996C Bis-(1h-indol-3-yl)-maleinimide derivatives and their use as pharmaceuticals
08/23/2001WO2001060825A1 Pyrrolopyrimidinone derivatives, process of preparation and use
08/23/2001WO2001060820A2 Matrix metalloproteinase inhibitors and uses thereof
08/23/2001WO2001060814A2 Pyrrole substituted 2-indolinone protein kinase inhibitors
08/23/2001WO2001060798A1 Amine derivatives for the treatment of apoptosis
08/23/2001WO2001060781A2 Diphenyl compounds, formulations and uses thereof
08/23/2001WO2001007029A3 Substituted guanidines and the use thereof
08/23/2001WO2001004116A3 Neurotrophic pyrrolidines and piperidines, and related compositions containing them
08/23/2001WO2000071508A3 Inhibitors of factor Xa
08/23/2001US20010016659 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
08/23/2001CA2397651A1 Amine derivatives for the treatment of apoptosis
08/23/2001CA2395841A1 Matrix metalloproteinase inhibitors and uses thereof
08/22/2001EP1125931A1 Biocidal alkyl-substituted-(hetero)aryl-ketoxime-O-ethers and the production method thereof
08/22/2001EP1125925A1 Amine derivatives for the treatment of apoptosis
08/22/2001EP1125923A2 Process for the preparation of N-methyl-2-pyrrolidinone (NMP)
08/22/2001EP1125922A1 Pyrrolidine compounds and medicinal utilization thereof
08/22/2001EP1124819A1 Method of lithiating five-membered heterocycles
08/22/2001EP1124801A1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress
08/22/2001EP1124798A1 Synthesis of methylthiophenyl hydroxyketones
08/22/2001EP1124528A1 Multivalent macrolide antibiotics
08/22/2001EP0907633B1 New synthetic catechol derivatives, method for production and use thereof
08/22/2001CN1309654A Biphenyl derivs.
08/22/2001CN1309636A 2-(2-chlorophenyl)-3,4-dihydro-2H-pyrrol derivs.
08/22/2001CN1309634A Hydrazine derivs.
08/22/2001CN1069898C Method for purification of N-vinylpyrrolidone by crystallization
08/21/2001US6277852 Piperazinyl 5-HT1 agonists and antagonists
08/21/2001US6277849 N-sulphonyl and N-sulphinyl amino acid amides as microbiocides
08/21/2001US6277833 3-hydroxy-3-methyl-glutaryl coenzyme a (hgm--coa) reductase inhibitors which retard cholesterol biosynthesis
08/21/2001US6277827 Stability makes the novel species suitable for milling, compression and improved bioavailability; 2s-(4-(2, 5-dioxopyrrolidin-1-yl)-2s-mercaptobutyrylamino)-4-methylpenta noic acid (2,2-dimethyl-1s-methylcarbamoylpropyl)amide
08/21/2001CA2196845C Hydroxamic acid compounds
08/21/2001CA2000362C Methyl .alpha.-arylacrylates substituted by a heterocyclic radical and their use
08/16/2001WO2001059067A2 A group of anti-cancer compounds with specific structure and their production method
08/16/2001WO2001058901A1 Pyrrolopyridazine compound
08/16/2001WO2001058891A2 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage
08/16/2001WO2001058871A1 Piperidyl carboxylic acids as integrin antagonists
08/16/2001WO2001058869A2 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
08/16/2001WO2001058855A1 Use of androgen receptor suppressors
08/16/2001WO2001058854A1 A topical antiandrogen for hair loss and other hyperandrogenic conditions
08/16/2001WO2001058588A1 Chiral ferrocene phosphines and their use in asymmetric catalytic reactions
08/16/2001WO2001010842A3 Melanocortin-4 receptor binding compounds and methods of use thereof
08/16/2001WO2001010429A3 Long chain n-alkyl compounds and oxa-derivatives thereof and use as antiviral compositions
08/16/2001WO2000076974A3 Oligomers and polymers of cyclic imino carboxylic acids
08/16/2001US20010014760 Gas-phase dehydration reaction process
08/16/2001US20010014683 Analgesics; side effect reduction
08/16/2001EP1123918A1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same
08/16/2001EP1123308A1 Single morphic forms of known peptide metalloproteinase inhibitors
08/16/2001EP1123272A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
08/16/2001EP1123098A1 Method for treating hot flashes in humans
08/16/2001EP0788498B1 Phenyloxazolidinone antimicrobials
08/16/2001DE10006694A1 New norbornenyl and 7-oxa- or 7-aza-bicyclo(2.2.1(hept-2-enyl N-heterocyclic compounds are useful as intermediates for active materials or other organic fine chemicals and in homo- and co-polymer production
08/16/2001DE10006453A1 New piperidylcarboxylic acid derivatives, are integrin antagonists useful for treating inflammatory, autoimmune or immunological diseases, e.g. atherosclerosis, asthma, diabetes, rheumatoid arthritis or transplant rejection
08/16/2001CA2400183A1 Chiral ferrocene phosphines and their use in asymmetric catalytic reactions
08/16/2001CA2399791A1 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
08/16/2001CA2399380A1 Pyrrolopyridazine compound
08/16/2001CA2398923A1 A group of anti-cancer compounds with specific structure and their production method
08/16/2001CA2398822A1 Piperazine and piperidine derivatives
08/15/2001CN1308616A Non-peptidyl inhibitors and VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory disease
08/15/2001CN1308610A Chiral compounds and their use as doping agents in liquid crystals
08/15/2001CN1308608A Substituted beta-amino acid inhibitors of methionine aminopeptidase-2
08/15/2001CN1308606A Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use pharmaceutical preparations comprising them
08/15/2001CN1308532A Mycobacterial inhibitors
08/15/2001CN1308251A Photographic element, compound and method containing azacyclo-substrated color former
08/15/2001CN1308074A Chiralheteraryl cyan alcohol and its derivative, preparation and use
08/15/2001CN1308056A Heterocyclic benzonitrile
08/14/2001US6274741 Process for the preparation of acyl heteroaromatic compounds from heteroaromatic compounds by metal ion exchanged clays
08/14/2001US6274740 Dissolving crystal form in solvent; drying
08/14/2001US6274613 Cyclic imines as pesticides
08/14/2001US6274607 N-linked ureas and carbamates of heterocyclic thioesters
08/14/2001US6274597 Method of enhancing lysosomal α-Galactosidase A